Refine by
Pharmaceutical Market Articles & Analysis
93 news found
Obtaining the Marketing Authorisation Application (MAA) is a key step in the commercialization of drugs in the EU, and also an important help to promote the global market expansion of pharmaceutical companies. ...
In the world of pharmaceutical ingredients, quality and efficacy has never been more important. ...
Always innovative and outstanding, Alfa Chemistry now has an extensive range of products within the pharmaceutical field, including PROTAC building blocks, nucleosides, intermediates and Active Pharmaceutical Ingredients (APIs). ...
This technology will expedite the implementation of clinical diagnostics and streamline market entry for pharmaceutical companies. Precision for Medicine incorporates scientific expertise and clinical trial excellence to deliver critical insights into patient biology. ...
Huateng Pharma, a distinguished provider of premium pharmaceutical intermediates, proudly unveils its latest breakthrough: Semaglutide Side Chain. ...
Our comprehensive collection includes mPEG36-NH2, NH2-PEG24-COOH, mPEG11-SPA, N3-PEG11-NH2, and many others, designed to meet the diverse needs of researchers and developers in the pharmaceutical and biotechnology sectors. Sonia, the Marketing Director of Biopharma PEG, emphasizes the excellence of our products, stating, "Our product is EXCIPACT GMP Certificated, ...
CD Formulation, a CRO service provider of analysis and testing services, offers a comprehensive range of tests for determining physical parameters in pharmaceutical formulations. These tests play a crucial initial role in ensuring the quality, stability, and efficacy of pharmaceutical products. ...
In the pharmaceutical industry, ensuring product safety and efficacy is paramount. Therefore, rigorous testing and analysis procedures are employed to ensure that pharmaceutical products meet the required standards. CD Formulation is emerging as a trusted partner specializing in biological determinations for pharmaceutical analysis and testing. ...
These new products are introduced to meet the growing demands of the pharmaceutical market. Tofacitinib Citrate Tofacitinib Citrate is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. ...
® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report results for the fourth quarter ended December 31, 2022, after the close of the financial markets on Thursday, March 16, 2023 and will hold a conference call at 4:30 p.m. ...
The U.S. Food and Drug Administration recently completed its regulatory inspection of the production site in Berlin and issued FARCO-PHARMA approval for the marketing of a sterile lubricant in disposable syringes in the United States. FARCO-PHARMA has been producing and selling the sterile catheter lubricant under the brand name GLYDO® on the U.S. market since October 2014. Medicinal ...
The International Society for Pharmaceutical Engineering is a long-established society that leads in the advancement of scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. ...
Cellworks Group Inc., a leader in Personalized Therapy Biosimulation, today announced the launch of its Precision Drug Development business units aimed at accelerating time-to-market for drug development and reviving previously studied but unapproved pharmaceutical assets through predictive biosimulation. The two new business units will use Cellworks’ ...
Distearyl phthalic acid amide, also known as N, N-Stearyl phthalic acid amide or N, N-Tollow phthalic acid amide, is proven to be applicable for manufacturing some cosmetics or pharmaceuticals. They can function as emulsifiers, suspending agents for cosmetics, triglycerides, mineral oil, silicones, and surfactants for pharmaceuticals. According to a ...
(NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced it has executed a Master Services Agreement (MSA) with Societal CDMO, Inc. ...
(SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of TPOXX to treat monkeypox. ...
(SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of TPOXX to treat monkeypox. ...
The therapeutic market for Parkinson’s Disease is over 10 million people with PD worldwide and growing. The top selling name brand product launched by the originator in 2007 independently sold over $375 million of its Rotigotine TDS patches in 2021. According to Wissen Market Research, total global sales for Rotigotine patches were approximately US$518 ...
(SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the U.S. ...
(SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced receipt of approximately $16 million of international procurement orders for oral TPOXX® (tecovirimat) in August and early September, including an approximate $10 million order by the European Commission, through funds from the European ...